The subsequent adverse reactions are already recognized during submit-approval usage of mycophenolic acid or other MPA derivatives.Subsequent oral or intravenous (IV) administration, MMF is metabolized to mycophenolic acid (MPA), the Lively component in mycophenolic acid delayed-launch tablets and also the active form of the drug. Usage of MMF in t